Naohide Ageyama

1.2k citations
54 papers · 910 indexed · h-index 17
Topics
Virus-based gene therapy research (13 papers)Mesenchymal stem cell research (8 papers)CRISPR and Genetic Engineering (7 papers)
Partner nations
JapanUnited StatesSpain

In The Last Decade

Naohide Ageyama

52 papers receiving 892 citations

Peers

Naohide Ageyama
Comparison fields: 5 of 95
  • Molecular Biology 370
  • Genetics 169
  • Genetics 163
  • Surgery 136
  • Cellular and Molecular Neuroscience 116
Replace Ché Serguera with:
Ché Serguera France
Michel Chofflon Switzerland
Michael V. Gonzalez United States
María Morell Spain
Levent Akyüz Germany
Jennifer Ishii United States
Tomonari Awaya Japan
Shoko Nakamura Japan
Toshiyuki Kaidoh Japan
Thomas Kammertoens Germany
Naohide Ageyama relative to Ché Serguera France Ché Serguera's profile →
Citations per field
00.5×3.4×
Ché Serguera · 1×
Citations per year

Countries citing papers authored by Naohide Ageyama

Since Specialization
Citations

This map shows the geographic impact of Naohide Ageyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohide Ageyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohide Ageyama more than expected).

Fields of papers citing papers by Naohide Ageyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohide Ageyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohide Ageyama. The network helps show where Naohide Ageyama may publish in the future.

Co-authorship network of co-authors of Naohide Ageyama

This figure shows the co-authorship network connecting the top 25 collaborators of Naohide Ageyama. A scholar is included among the top collaborators of Naohide Ageyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohide Ageyama. Naohide Ageyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 8
6 11
7 6
8 19
9 18
10 18
11 43
12 53
13 39
14 10
15 14
16 10
17 8
18 14
19 5
20 14

About Naohide Ageyama

Naohide Ageyama is a scholar working on Virology, Developmental Neuroscience and Genetics, having authored 54 papers that have together received 910 indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Mesenchymal stem cell research (8 papers) and CRISPR and Genetic Engineering (7 papers). The work is most often cited by research in Developmental Neuroscience (105 citations), Genetics (169 citations) and Virology (44 citations). Naohide Ageyama has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Keiji Terao, Hiroaki Shibata, Tatsuhiro Hisatsune, Yutaka Hanazono, Kenneth Aizawa, Keiya Ozawa, Fumiko Ono, Yasuji Ueda, Chihiro Yokoyama and Yasuhiro Yasutomi. Their work appears in journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026